Actover Pharmaceutical Group Participates in the 10th IRAN PHARMA Exhibition

Author:
Actoverco
Date:
28 September 2025
4R4A5641-1-2048x1365

Actover Pharmaceutical Group, with active participation in the 10th edition of the Pharmaceutical and Related Industries Exhibition (IRAN PHARMA), hosted chief executives of several pharmaceutical companies, manufacturers and industrial players in the pharmaceutical supply chain, trade delegations, colleagues, student groups, and various domestic and international visitors. The three-day exhibition provided a valuable opportunity to expand exchanges and foster joint cooperation in scientific, manufacturing, and export fields.

According to the Public Relations Department of Actover Group, the presence of 736 domestic and foreign companies from over 28 countries at this year’s exhibition created a suitable platform for sharing experiences, presenting innovations, and addressing both domestic and international challenges in the pharmaceutical industry.

The pavilion of Actover Pharmaceutical Group at IRAN PHARMA 2025, featuring its subsidiaries Actoverco, Actero, Ati Pharmed, Alborz Zagros, Actobiochem, and Nexus, also hosted senior officials from the Food and Drug Administration and key figures in the country’s pharmaceutical production sector, including Dr. Mehdi Pirsalehi, Deputy Minister of Health and Head of the Food and Drug Administration, and Dr. Ebrahim Sheikh, Deputy Minister for General Industries at the Ministry of Industry, Mine and Trade. They visited Actover’s latest pharmaceutical products and held direct discussions with the CEOs and board members of the subsidiaries to hear their perspectives on pharmaceutical issues.

One of the noteworthy aspects of this year’s IRAN PHARMA exhibition was the significant participation of student groups, whose presence at the booths of major pharmaceutical companies, including Actover Group, brought a dynamic and lively atmosphere to the event.

Other key programs of this year’s exhibition—held under the theme “Sustainability, Resilience, and Innovation in the Pharmaceutical Supply Chain” with special emphasis on sustainable development, strengthening industry resilience against crises, and innovation in pharmaceutical production and supply included:

  • Specialized meetings with ambassadors from target export countries,

  • Review of the new regulations of the Iranian Drug List Council,

  • Roundtable discussions between industry representatives and FDA managers,

  • Examination of solutions to address reimbursement issues and export challenges.

IRAN PHARMA, as a comprehensive international exhibition in the pharmaceutical sector, annually hosts pharmaceutical product manufacturers, active pharmaceutical ingredient producers, distributors, equipment and machinery manufacturers, pharmaceutical printing and packaging service providers, biotech and recombinant drug producers, startups and emerging companies, herbal medicine and dietary supplement manufacturers, academic and research institutions, associations, and media representatives.

The 10th edition of the exhibition was held from September 23–25, 2025, at the Imam Khomeini Grand Mosalla in Tehran.

Related Posts

4R4A5641-1-2048x1365

Actover Pharmaceutical Group Participates in the 10th IRAN PHARMA Exhibition

4R4A3136-2048x1365 (1)

Actoverco Medical Director Stated: A Strong Commitment to the “Pharmacovigilance” System Ensures the Safety and Reliability of Actover Products

M_HA18361-2048x1365

Actover Group Unveils “Zeponim” for the Management of Multiple Sclerosis and Ulcerative Colitis

nexus23

Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025

4R4A0525

Actover Pharmaceutical Group Showcases Its Neurology Portfolio at the 32nd Iranian Congress of Neurology and Clinical Electrophysiology